Marshall Wace, LLP Sutro Biopharma, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 30,661 shares of STRO stock, worth $59,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,661

Holding current value

$59,175

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.88 - $5.01 $88,303 - $153,611	30,661 New	30,661 $106,000
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $1.53 Million - $2.89 Million	-342,010 Reduced 61.08%	217,905 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $196,350 - $293,255	36,294 Added 6.93%	559,915 $4.52 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $261,695 - $359,893	-50,618 Reduced 8.81%	523,621 $2.91 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $1.57 Million - $4.11 Million	459,344 Added 399.79%	574,239 $2.99 Million
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $3.71 Million - $4.9 Million	-205,549 Reduced 64.15%	114,895 $2.14 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $149,009 - $202,253	7,344 Added 2.35%	320,444 $7.29 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $3.18 Million - $7.51 Million	313,100 New	313,100 $6.8 Million

Others Institutions Holding STRO

# of Institutions

137

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

Suvretta Capital Management, LLC New York, NY

7.19M
Shares

$13.9 Million
0.98% of portfolio
Black Rock Inc. New York, NY

6.91M
Shares

$13.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.2M
Shares

$8.1 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3M
Shares

$5.79 Million
0.03% of portfolio
Bio Impact Capital LLC Cambridge, MA

2.83M
Shares

$5.47 Million
1.53% of portfolio

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $101M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account